Data management

Exciting line-up and speakers for the 7th IPF Annual Summit in Boston next month

30-Aug-2023 By Liza Laws

With more than 63 biopharma companies attending and 15 event partners sharing solutions, the 7th Annual IPF Summit being held in Boston next month (September 2023) is not to be missed.

'Significant milestone' as STARLIMS acquires Labstep to unlock lab data's full potential

25-Aug-2023 By Liza Laws

STARLIMS, a company that provides enterprise informatics solutions has acquired Labstep, a research and development (R&D) electronic laboratory notebook (ELN).

Mahana Therapeutics and Bayer in multi-million dollar partnership to commercialize digital therapeutics

24-Aug-2023 By Liza Laws

Mahana Therapeutics announced last week (August 22) that it was entering into a multi-million dollar distribution and marketing partnership with the consumer health division of Bayer.

Oracle joins White House CancerX initiative to wage war on cancer

24-Aug-2023 By Liza Laws

Cloud services and life sciences company, Oracle, has been recognized as a founding member of The White House's public-private partnership CancerX.

DIA Global

Watch Yseop showcase Copilot 'the world's most secure automation solution'

23-Aug-2023 By Liza Laws

Another company OSP was lucky enough to catch up with at DIA Global in Boston this year, was well-established generative artificial intelligence (AI) software company, Yseop.

Lokavant interview: The company's expansion across real world data and why the industry needs to be wary of AI

17-Aug-2023 By Liza Laws

Rohit Nambisam is CEO of Lokavant, OSP caught up with him at DIA Global in Boston earlier this summer to find out more about him and the work he is passionate about.

Seed round of $2.25M secured for LighthouseAI's compliance product suite

14-Aug-2023 By Liza Laws

LighthouseAI, a company that specializes in compliance solutions for the pharmaceutical supply chain, has announced a $2.25 million seed round, led by Healthy Ventures with participation from Bertelsmann Next.

Interview: Phastar's Stephen Corson on his passion for stats and why they are so important for all health-related areas

07-Aug-2023 By Liza Laws

OSP was fortunate enough to have an interesting discussion with Stephen Corson, who is a statistics manager at Phastar, a specialist biometrics CRO headquartered in the UK.

CluePoints announces full agenda and speakers for free RBQM event next month

04-Aug-2023 By Liza Laws

Risk-based quality management (RBQM) is used to identify and assess risks then finding ways to manage them and is an important part of clincal trials.

Mural Health - giving power to the patients wanting to take part in clinical trials

11-Jul-2023 By Liza Laws

Jason Dong, co-CEO-founder of Mural Health, wants to make sure patients taking part in trials are not out of pocket. He joined OSP while at DIA Global to discuss how his business came about and why it is so important.

Verana Health's CEO on replicating studies with real-world data, diversity and patient focus

06-Jul-2023 By Liza Laws

With the FDA issuing guidance on more diversity within clinical trials, it is a subject many companies are being encouraged to focus on, each with their own approach.

Koneksa partners with Beacon Biosignals to 'revolutionize drug development' in clinical trials

15-Jun-2023 By Liza Laws

The digital biomarkers company has partnered with Beacon Biosignlas, a computational neurodiagnostics company to launch a clinical trial investigate the integration of Beacon’s at-home electroencephalogram (EEG) into Koneksa’s neuroscience solution toolkit.

How generative AI could change the life sciences landscape - an interview with Indegene

07-Jun-2023 By Liza Laws

With generative AI continuing to create a buzz, OSP took the opportunity to speak to Indegene, a digital-first, life sciences commercialization company that helps biopharmaceutical, emerging biotech and medical device companies develop products. Talking...

'Exciting results' for Grail and UK's Oxford University study with multi-cancer detection test

06-Jun-2023 By Liza Laws

A healthcare company on a mission to produce a multi-cancer early detection (MCED) test so patients have more chance of being cured, has produced 'exciting results' from a study.

Wearable monitor a 'game changer' in Parkson's fight, study shows

31-May-2023 By Liza Laws

Studies show a wearable monitor, described as a ‘game changer’ in the fight against Parkinson’s Disease (PD) has proven it is more than 95% accurate, PD Neurotechnology says.

Charm Therapeutics gains investment from NVentures to develop therapeutics for cancer

16-May-2023 By Charm Therapeutics gains investment from NVentures for cancer therapeutics

Charm Therapeutics has announced investment from NVentures – NVIDIA’s venture investment arm. This represents a major milestone for Charm and means it will be able to deliver more on its research and development (R&D) activities for novel oncology...

One of Germany’s biggest research organizations selects DDN for AI-driven discoveries

11-May-2023 By Liza Laws

Helmholtz Munich, one of Germany’s 19 research centers, that develops future solutions and technologies has selected DataDirect Networks (DDN) to accelerate its artificial intelligence (AI) driven discoveries.

Strateos shifts strategy to on-site cloud labs

24-Apr-2023 By Ben Hargreaves

The company announces plans to reorganize its business to focus on design-and-deployment engagements for on-site implementation of automated cloud labs.

University becomes Freenome's study partner for multi-cancer screening approach

13-Apr-2023 By Liza Laws

The Institute for Population and Precision Health (IPPH) at the University of Chicago has joined private biotech company, Freenome, to become its partner as part of a study.

Breakthrough that could put an end to invasive surgery for rectal cancer patients

12-Apr-2023 By Liza Laws

A breakthrough in rectal cancer treatment has been discovered through a collaboration between a cancer intelligence company and the world’s largest and oldest cancer center. It could put an end to the invasive surgery patients may have faced.

Interview with Indegene: Challenges and future of pharmacovigilance (PV) Compliance

11-Apr-2023 By Liza Laws

OSP spoke to Vladamir Penkrat, head of safety and regulatory and Shuba Rao a senior director at Indegene, a life sciences digital company about a paper they recently published called 'Challenges and Future of PV Compliance' about the direction...

Mirum Pharmaceuticals success with study of drug for chronic liver disease

06-Apr-2023 By Liza Laws

A small molecule drug to treat a chronic liver disease has been proven to support treatment across the broadest range of genetic types ever studied.

Powerful tool for capturing aneurysms from Viz.ai given funding and FDA clearance

23-Mar-2023 By Liza Laws

A powerful tool that could capture abdominal aortic aneurysms (AAA) and refer those at risk is the first to be given clearance by the US Food and Drink Administration (FDA).

Interview: Women's health and access to clinical trials is 'severely underinvested in - and the facts don't lie' - Medable's CGO

22-Mar-2023 By Liza Laws

In the second and final part of an interview with Medable’s chief growth officer and women’s health champion, Sanskriti Thakur, discover her views on vital changes that need to be made. She discusses ways to ensure the importance of women’s roles in clinical...

Drug discovery timelines accelerated as Iktos develops AI and drug capabilities with series A funding

21-Mar-2023 By Liza Laws

Iktos, a company specializing in artificial intelligence (AI) for new drug discovery has closed a €15.5 million series A funding round.

CatSci Ltd and AGC Pharma Chemicals announce their strategic partnership

16-Mar-2023 By Liza Laws

Medicine developer, CatSci Ltd announced yesterday (March 15) that it has formed a new partnership with AGC Pharma Chemicals, a small molecule Contract Development and Manufacturing Organisation (CDMO).

Noema Pharma raises $112M in Series B financing for nervous system disorders

16-Mar-2023 By Liza Laws

Oversubscribed, series B financing for Noema Pharma’s clinical stage assets has been successfully closed raising $112 million from new and existing investors.

Global 'Cancer Grand Challenges' initiative outlines nine toughest challenges to tackling the disease

15-Mar-2023 By Ben Hargreaves

A research initiative co-led by Cancer Research UK and the National Cancer Institute announces funding to tackle core challenges in cancer treatment.

LEO Pharma and ICON plc collaborate to improve outcomes for dermatology patients

14-Mar-2023 By Liza Laws

A strategic partnership between LEO Pharma and ICON plc, a clinical development company, was announced on March 10.

Interview: Lessons learned during Covid and what the future holds for hybrid and decentralised trials

08-Mar-2023 By Liza Laws

When the pandemic broke, the whole world was thrown onto a steep learning curve. Everyone had to find new ways to adapt in their day to day lives as well as their working lives. There was no exception with clinical trials, with patients unable to attend...

International Women's Day interview: Addressing the balance of women in medicine, research and clinical trials

08-Mar-2023 By Liza Laws

In the first of a two-part interview with Medable’s chief growth officer, Sanskriti Thakur, we will learn about why she thinks the world of medicine is letting women down, what the future holds and how everyone should be paying more attention.

News in brief: Greenphire's ConneX 'supports trial retention'

07-Mar-2023 By Liza Laws

A clinical trial travel solution that can remove administrative burdens for research sites and eliminate logistical and financial barriers for participants has significantly expanded.

SCOPE 2023

Double win for StudyKIK's oncology and cash apps helping trial patients

02-Mar-2023 By Liza Laws

Year on year, the SCOPE summit brings thousands of people working in the pharma field together and the last one attracted more than 2,300 leaders in clinical operations and research.

How blockchain could improve data management in healthcare supply chains

11-Jan-2023 By Nick Taylor

The cryptocurrency space suffered through a torrid, scandal-marked 2022 but there remains interest in using the blockchain infrastructure that underpins the sector in other contexts. In a recent review of the potential of the blockchain in healthcare,...

Digital twins provide potential fix for growth in volume and variety of research data: Study

11-Jan-2023 By Nick Taylor

Digital twins could overcome common data management issues at equipment-intense research facilities, according to a paper published in the journal Sensors.

Medidata reveals patient app to support decentralized trials

13-Dec-2022 By Ben Hargreaves

The company states that the new app is able to cut study start-up times for sponsors and CROs, while it can also be used by patients across various different platforms.

‘Data is the key’: Strategic partnership leverages AI for cancer clinical trial placement

23-Nov-2022 By Maggie Lynch

Partnership between Massive Bio and Azra AI extends clinical care teams bandwidth to place cancer patients in trials while eliminating unconscious bias.

Medable launches new tool for global remote consent

15-Nov-2022 By Ben Hargreaves

The company announces that Total Consent, an SaaS electronic management solution, is now available across more than 120 different locations globally.

Clario releases 20 years of data working on decentralized trials

10-Nov-2022 By Ben Hargreaves

The company reveals some of its data on the number of trials and patients that have been supported through its tools.

Oracle and ObvioHealth come together for ‘tight integration’ of data in APAC DCTs

10-Nov-2022 By Maggie Lynch

Oracle and ObvioHealth collaborate on clinical trial solutions using ObviGo to establish a “more complete clinical research ecosystem” in Asia Pacific region.

Benefiting from Bristol Myers’ input, ConcertAI rolls out digital trial solution

24-Oct-2022 By Nick Taylor

ConcertAI has introduced a digital trial solution informed by its collaboration with Bristol Myers Squibb to simplify patient identification, consent, IRB approval, and contract negotiations.

Science 37 taps NuvoAir to enable remote collection of lung health endpoints

20-Sep-2022 By Nick Taylor

Science 37 has partnered with NuvoAir to incorporate connected devices for the remote collection of respiratory endpoints data into clinical trial designs.

Bayer taps Clariness to build patient insights into clinical trial review process

13-Sep-2022 By Nick Taylor

Bayer Pharma has enlisted Clariness to support its new study review process by providing pre-clinical trial patient insights and post-trial feedback.

Use of RWE, AI elevating drug development: Sidley

12-Sep-2022 By Jenni Spinner

A fleet of legal professionals offers advice and perspective on important considerations when harnessing artificial intelligence and real-world evidence.

Real-world evidence helps accelerate research: Wolters Kluwer Health

12-Sep-2022 By Jenni Spinner

Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines.

DiMe releases digital health resources for atopic dermatitis endpoint

08-Sep-2022 By Jenni Spinner

The Digital Medicine Society is offering a library of resources to help promote the use of nocturnal scratch as an endpoint for the troubling skin condition.

Clarify, Datavant team up to securely connect first-party and real-world data

07-Sep-2022 By Nick Taylor

The companies will work together to help clients connect information sources, giving stakeholders a better overview of the clinical patient experience.

Sanofi strikes $20m AI drug discovery deal with Atomwise

07-Sep-2022 By Nick Taylor

The pharma company’s collaboration with the drug discovery specialist involves using artificial intelligence to discover and develop up to five drug targets.

CVS Health agrees to acquire Signify Health

06-Sep-2022 By Jenni Spinner

With the purchase, the company is looking to advance its plans to connect with potential trial participants and spread awareness of study participation.

DTRA glossary aims to promote adoption of decentralized format

06-Sep-2022 By Jenni Spinner

The Decentralized Trials and Research Alliance is offering the research resource to increase awareness, understanding, and acceptance of the study format.